Copycat versions of Eli Lilly’s diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They’re still available on some websites.
Related Posts
Shares of iRobot tank 30% after Roomba maker raises doubt about its survival
Its financial situation has worsened since Amazon walked away from its $1.7 billion acquisition of iRobot last year, citing regulatory hurdles.
Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 30%
Novo Nordisk is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy copycats, with rare exceptions.
Trump gets high approval ratings for his first weeks, new CBS poll finds
President Donald Trump received positive marks on immigration policy, his handing of the Israel-Hamas conflict and more.